ReviewMicrosystems & nanoengineering2025
Surface-enhanced spectroscopy technology based on metamaterials.
Review in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Electrically Tunable VONanomaterials (Basel, Switzerland) · 2026Article
- Ultrasensitive, Selectivity Detection of Mercury Ion Using a Novel Localized Surface Plasmon Resonance Biosensor.Sensors (Basel, Switzerland) · 2026Article
- Addressing the Challenges of Solid-State Nanopores: Strategies for Performance Enhancement.International journal of molecular sciences · 2026Review
- Broadband plasmon modulation and high-intensity nanofocusing for high-resolution nanoscale imaging using Fabry-Pérot probes.Microsystems & nanoengineering · 2026Article
- The Challenge of Measuring Exercise: Advancing Metrological Barriers in Wearable Sensing.JMIR mHealth and uHealth · 2025Review
- AI‑driven photonic noses: from conventional sensors to cloud‑to-edge intelligent microsystems.Microsystems & nanoengineering · 2025Review
- The optoelectric tunability effect of structurally patterned FeScientific reports · 2025Article
- A Composite Substrate of Ag Nanoparticle-Decorated Inverse Opal Polydimethylsiloxane for Surface Raman Fluorescence Dual Enhancement.Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Surface-enhanced spectroscopy technology based on metamaterials has flourished in recent years, and the use of artificially designed subwavelength structures can effectively regulate light waves and electromagnetic fields, making it a valuable platform for sensing applications. With the continuous improvement of theory, several effective universal modes of metamaterials have gradually formed, including localized surface plasmon resonance (LSPR), Mie resonance, bound states in the continuum (BIC), and Fano resonance. This review begins by summarizing these core resonance mechanisms, followed by a comprehensive overview of six main surface-enhanced spectroscopy techniques across the electromagnetic spectrum: surface-enhanced fluorescence (SEF), surface-enhanced Raman scattering (SERS), surface-enhanced infrared absorption (SEIRA), terahertz (THz) sensing, refractive index (RI) sensing, and chiral sensing. These techniques cover a wide spectral range and address various optical characteristics, enabling the detection of molecular fingerprints, structural chirality, and refractive index changes. Additionally, this review summarized the combined use of different enhanced spectra, the integration with other advanced technologies, and the status of miniaturized metamaterial systems. Finally, we assess current challenges and future directions. Looking to the future, we anticipate that metamaterial-based surface-enhanced spectroscopy will play a transformative role in real-time, on-site detection across scientific, environmental, and biomedical fields.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.